Data / Form D filings / Cognos Therapeutics Inc
Cognos Therapeutics Inc: Form D filings
Cognos Therapeutics Inc, a biotechnology company in Inglewood, CA, filed 11 Form D notices with the SEC between 2015 and 2026. The latest, on July 2, 2026, reports $250,000 sold of a $2 million offering.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 10604 S. LA CIENEGA BLVD., Inglewood, CA, 90304
- Phone
- (310) 641-2700
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1651490
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jul 2, 2026 | New notice | $2,000,000 | $250,000 | $1,750,000 | 0 | May 21, 2026 | sec.gov |
| Mar 31, 2022 | New notice | $2,100,000 | $0 | $2,100,000 | 0 | Yet to occur | sec.gov |
| Oct 12, 2021 | New notice | $3,000,000 | $55,250 | $2,944,750 | 3 | Sep 30, 2021 | sec.gov |
| Jul 16, 2021 | New notice | $600,015 | $600,015 | 1 | Jun 30, 2021 | sec.gov | |
| May 21, 2021 | Amendment | $14,280,000 | $3,816,795 | $10,463,205 | 117 | Feb 7, 2018 | sec.gov |
| Dec 29, 2020 | New notice | $1,000,025 | $1,000,025 | 1 | Dec 14, 2020 | sec.gov | |
| May 29, 2018 | New notice | $1,600,000 | $66,878 | $1,533,122 | 4 | May 17, 2018 | sec.gov |
| Feb 15, 2018 | New notice | $14,280,000 | $49,997 | $14,230,003 | 1 | Feb 7, 2018 | sec.gov |
| Apr 20, 2016 | New notice | $880,000 | $48,000 | $832,000 | 2 | Apr 8, 2016 | sec.gov |
| Dec 10, 2015 | Amendment | $45,312,000 | $160,000 | $45,152,000 | 5 | Sep 10, 2015 | sec.gov |
| Aug 24, 2015 | New notice | $45,312,000 | $0 | $45,312,000 | 0 | Yet to occur | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Frank Adell | Executive Officer, Director | |
| Thomas Chen | Director | |
| Eli Gang | Director |
Other biotechnology companies in California that filed recently
- Trellis Bioscience, Inc. $9.1 million · Oct 29, 2026
- BigHat Biosciences, Inc. $75.1 million · Oct 26, 2026
- Theravie Pharma, Inc. $750,000 · Oct 19, 2026
- Adela, Inc. $12 million · Oct 19, 2026
- Estuary Biotherapeutics, Inc. $40.7 million · Oct 16, 2026
- Renue Life Sciences, Inc. $250,000 · Oct 14, 2026
Every Form D from the week of Jun 29, 2026 · All recent filings in California · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Cognos Therapeutics Inc reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.